investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Christopher S Garris

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Christopher S Garris

Harvard University

Cambridge, United States

Related projects

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

Jonathan M Kurie

Regulation of Lung Cancer Metastasis by ZEB1

Trachea, bronchus and lung

Jonathan M Kurie

Regulation of Lung Cancer Metastasis by a Procollagen Lysine Hydroxylase

Trachea, bronchus and lung

Yanxiang Guo

The role of autophagy in Kras-driven lung cancer

Trachea, bronchus and lung

Pathology

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Peter S Hammerman

Genomic Discovery and Targeted Therapeutics in Squamous Cell Lung Cancer

Trachea, bronchus and lung

Susan Bates

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

Trachea, bronchus and lung

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Curtis Harris

Integrative Molecular Epidemiology of Human Cancer

Trachea, bronchus and lung

Hematology and hematologic malignancies